Google
RGC — REGENCELL BIOSCIENCE HOLDINGS LTD (Healthcare >> Drug Manufacturers - Specialty & Generic)
RGC FAQ
What is RGC's ROE?
REGENCELL BIOSCIENCE HOLDINGS LTD reports a Return on Equity (ROE) of -806.06%.
What is RGC's dividend yield?
REGENCELL BIOSCIENCE HOLDINGS LTD offers a dividend yield of 0.00%.
What is RGC's Deepscope Quality Score?
Deepscope rates RGC's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy RGC?
Deepscope's AI Timing Score for RGC is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does RGC belong to?
REGENCELL BIOSCIENCE HOLDINGS LTD is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 19.99
Price
-2.17
(-9.79%)
Day Change
|
|
|---|
RGC, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 45 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 19.99 |
| PBV / Sector |
8,394.34 / 2.76
|
| Earning Per Share | -0.02 |
| PE / Sector |
N/A / 23.64
|
| PEG or PE/Growth / Sector |
N/A / 0.13
|
| Average 1M Daily Value |
2.40 M
GREAT
|
| Average 1W Daily Value |
2.06 M
GREAT
|
| Timing Factors |
|
14% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:09:01 |
| Symbol | RGC |
| Name | REGENCELL BIOSCIENCE HOLDINGS LTD |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 494.49 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 10,235.92 / 9,835.56 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Chinachem Leighton Plaza, Causeway Bay, Hong Kong
Phone: 852 2155 0823
Website: https://www.regencellbioscience.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
